OR56B2P

Across TCGA pan-cancer cohorts, OR56B2P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of OR56B2P’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where OR56B2P RNA is repressed in tumor relative to normal tissue. In most cancer types OR56B2P is over-expressed in tumor, although a few such as LUSC and UCEC show the opposite, repressed pattern.

LUSC, UCEC, and BRCA are the cancer types where OR56B2P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR56B2P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Female	All	−0.052	.003	4	view →
UCEC	All	All	−0.028	.044	2	view →
BRCA	Female	II,III,IV	−0.022	.011	2	view →
KIRP	All	All	−0.009	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

OR56B2P–LUSC

Open the LUSC breakdown →